Future research directions could focus on understanding the precise mechanisms by which p53 and its associated proteins regulate the EMP in CRC, translating these mechanistic insights into dependency-targeting therapeutics that offer alternative treatment paradigms
A detailed review could help identify these gaps and propose directions for future research [Risks and benefits of antioxidant supplement use during cancer treatment (12)]
Key benefits of peptide therapy While individual results vary, and the specific benefits depend on which peptide is used, the potential applications are vast
Therefore, it seems that there may be a methionine-induced hypermethylation of CpG island-containing promoters in patients with SZ treated with methionine
#UKLifeSciencesUK To view or add a comment, sign in Learn more about how our aligned pathway with Medicines and Healthcare products Regulatory Agency will deliver faster patient access to medicines, and streamline the regulatory process for industry Our much-anticipated fireside chat was led by two prominent figures in the industry: Samantha Roberts, Chief Executive of the NICE - National Institute for Health and Care Excellence, and Lawrence Tallon, Chief Executive Officer of the Medicines and Healthcare products Regulatory Agency (MHRA)
